Global Viscosupplementation Market Size To Worth USD 9.15 Billion By 2033 | CAGR Of 8.10% [Yahoo! Finance]
Anika Therapeutics Inc. (ANIK)
Last anika therapeutics inc. earnings: 2/20 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.anikatherapeutics.com/investor-relations
Company Research
Source: Yahoo! Finance
to Reach USD 9.15 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies Covered: Sanofi, Hoffmann-La Roche, Bioventus, Zimmer Biomet, Anika Therapeutics Inc., Seikagaku Corporation, Mylan N.V., Aptissen, Ferring Pharmaceuticals, OrthogenRx, Johnson and Johnson, Ono Pharmaceuticals, Lifecore Biomedical, F.Hoffmann, and other key vendors. New York, United States , June 14, 2024 (GLOBE NEWSWIRE) -- The Global Viscosupplementation Market Size is to Grow from USD 4.20 Billion in 2023 to USD 9.15 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 8.10% during the projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4533 Viscosupplementation is a medical treatment in which a gel-like substance called hyaluronic acid is injected into a joint, typically the knee, to help primarily alleviate joint pain, most commonly associated with osteoarthritis. Viscosupplementation is a treatment for os
Show less
Read more
Impact Snapshot
Event Time:
ANIK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIK alerts
High impacting Anika Therapeutics Inc. news events
Weekly update
A roundup of the hottest topics
ANIK
News
- Facial Injectables Global Strategic Analysis Report 2024: Market to Grow by Over $10 Billion During 2023-2030 [Yahoo! Finance]Yahoo! Finance
- HealthpointCapital and The Orthopaedic Summit: Evolving Techniques Course (OSET) Announce Inaugural Investor Day at Fontainebleau Las Vegas [Yahoo! Finance]Yahoo! Finance
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "equal weight" rating re-affirmed by analysts at Stephens. They now have a $24.00 price target on the stock.MarketBeat
- Anika Enters into Cooperation Agreement with Caligan Partners [Yahoo! Finance]Yahoo! Finance
ANIK
Earnings
- 5/8/24 - Miss
ANIK
Sec Filings
- 6/25/24 - Form DEFA14A
- 6/11/24 - Form ARS
- 6/11/24 - Form DEF
- ANIK's page on the SEC website